IL6 and B-cell chronic lymphocytic leukemia: We further showed that the Th17-promoting cytokines IL-6 and IL-1 are elevated in a subset of CLL patients and are members of a cluster of cytokines whose presence correlates with longer TTFT and longer overall survival in this disease [26].